Katrin Pribbernow und Christoph Keck - Info zur Person

(1 - 8 von 8

)

Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian...

1library.net

Katrin Pribbernow. 3. , Christoph Keck. 4. and Inka Wiegratz. 5*. Abstract. Background:The use of recombinant human follicle-stimulating hormone (r-hFSH) in ...

Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian...

rbej.biomedcentral.com

· Katrin Pribbernow. amedes MDL, Hamburg, Germany. Christoph Keck. Kinderwunsch & Hormonzentrum Frankfurt – Am Palmengarten, Private ...

12th Congress of the European Society of Gynecology

esg2017.esgynecology.org

Inka Wiegratz (DE), Regina Schneidereit (DE), Peter Sydow (DE), Katrin Pribbernow (DE), Christoph Keck (DE). [Wiegratz] VivaNeo Kinderwunschpraxis ...

Patient preferences for characteristics differentiating ovarian...

www.wizdom.ai

... clinical practice: a multicenter, prospective, open, non-interventional a · Peter Sydow, Norbert Gmeinwieser, Katrin Pribbernow, Christoph Keck, Inka Wiegratz.